Management

The high level of first-in-class development in pancreatic cancer therapeutics is a promising sign of the industry seeking…

Modest growth will be primarily due to lack of hypertension awareness, leading to low diagnosis and treatment rates

Analysing recent preliminary research on the 'placebome' - a set of genes that trigger some placebo responders to respond to the…

Struggling to balance R&D expenditure and profitability, pharma companies are outsourcing R&D and clinical trial…

Treatment market value across eight major countries to reach $4.7 billion by 2022

M&A typically low in gene therapy field as technology remains highly experimental and majority of products are in early-stage…

The Ministry of Commerce, Government of India has released the new Foreign Trade Policy for 2015-2020, to be amended from June 30,…

The US Pharmacopeial Convention (USP), recently brought together national medicines control laboratory officials for a workshop in…

India has highest number of US FDA approved manufacturing facilities outside the US and yet the Indian pharma industry faces…

Dr Martin Robinson, Executive Vice President and International Academy of Clinical Research (IAOCR) Ambassador, talks about…